Skip to content

XORTX
  • About
    • Management Team
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Coronavirus – COVID-19 Program
    • Autosomal Dominant Polycystic Kidney Disease
    • Diabetic Nephropathy
  • Strategic Partnerships
  • Investors
    • Press Releases
    • Presentations
    • Media
    • Independent Research
    • Financials
    • SEDAR
    • Transfer Agent
    • Upcoming Events
  • Contact
Site Search

Legal Disclaimer

This web site contains forward-looking statements reflecting XORTX Pharma Corp.’s current plans and objectives for future results which are based on various factors and assumptions. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including, without limitation, the company’s ability to successfully complete pre-clinical and clinical development of its products, the ability to attract and retain corporate alliances relating to the development and commercialization of its technologies and products, decisions and the timing of decisions made by health regulatory agencies regarding approval of XORTX Pharma Corp.’s products, the ability to obtain timely patent and other intellectual property protection for its technologies and products, the competitive environment and the impact of technological advances, and the uncertainty of access to capital required to finance the company’s activities.. These factors should be considered carefully and readers should not place undue reliance on XORTX Pharma Corp.’s forward-looking statements. XORTX Pharma Corp. assumes no obligation to update these forward-looking statements to reflect actual results, changes and assumptions or changes in other factors affecting such statements.

Press Releases

  • XORTX Confirms $1 Million in Warrant Exercise Proceeds March 2, 2021
  • XORTX Participating in WuXI Healthcare Forum March 1, 2021
  • XORTX to Present at BIO CEO and Investor Conference February 17, 2021
  • XORTX Closes Over Subscribed Private Placement February 10, 2021
  • XORTX Announces Over Subscribed Private Placement February 8, 2021
XORTX Therapeutics Inc.
4000, 421 7th Avenue SW
Calgary, Alberta T2P 4K9
Ph: +1 (403) 455-7727
info@xortx.com
Theme by Colorlib Powered by WordPress